Life science & clinical diagnostics instruments > Genomics

Major genome release paves way for future biotech products

15 June, 2017

A major release of reference genomes is expected to pave the way for future health, biotechnology and agricultural products.


Cutting-edge genomics sequencer arrives in Brisbane

26 May, 2017

The city of Brisbane has become home to what is claimed to be the world's most advanced genomics sequencer.


Merck develops new genome editing tool

18 May, 2017

Science and technology company Merck has developed a new genome editing tool that is said to make CRISPR more efficient, flexible and specific.


International funding for Australian epigenome researcher

10 May, 2017

Australian epigenetics and genomics researcher Ryan Lister has been chosen alongside 40 researchers from 16 countries to receive a prestigious international scholarship that will fund his research.


Illumina NovaSeq series of sequencing systems

01 March, 2017

The NovaSeq series of systems feature innovations that leverage Illumina next-generation sequencing (NGS) technology. They offer users scalable throughput and flexibility for virtually any sequencing method, genome or scale of project.


'Omics for all — genomic technology conference

08 August, 2016

The AGTA conference, Australia's foremost genomic technology conference, is an essential event for researchers and industry representatives who work with genomic technologies in a variety of contexts including platform development, medical genomics, functional genomics, non-model systems, epigenomics and plant genomics.


Fast test for inherited mitochondrial disease

11 July, 2016

Rapid diagnosis of mitochondrial disorders is becoming a reality via a new genetic test.


Genomics to disrupt business as usual in the clinical laboratory

22 June, 2016 by Gene Elliott* and Martin Wilkinson^

The discovery of the genetic code has until recently had limited application in the routine clinical laboratory and for the man in the street. This is set to change as advances in genomics technology make it more accessible.


Down syndrome gene points to the cause of diabetes

24 May, 2016

The genetics of individuals with Down syndrome have provided researchers with a method to identify a single gene that may be responsible for defective insulin secretion in type 2 diabetes.


Why do all animal embryos look the same?

03 March, 2016

An international team of biologists has shed light on why all vertebrate animals look alike during the phylotypic stage of embryo development.


Hard to get up in the morning — blame your genes

05 February, 2016

The personal genetics company 23andMe has released the results of one of the largest genome-wide association studies of its kind, identifying genetic variants associated with being a morning person.


Gene editing saves Layla from leukaemia

22 January, 2016 by Lauren Davis

In an impressive demonstration of the power of gene editing, designer immune cells have been successfully used to treat an infant cancer patient.


An advance in Alzheimer's research

11 December, 2015 by Graeme O'Neill

Researchers have identified a network of genes whose interactions influence the age at which carriers of the pathogenic E280A gene mutation will develop Alzheimer's disease.


IDT xGen Exome Research Panel v1.0

11 November, 2015

Integrated DNA Technologies (IDT) introduces its xGen Exome Research Panel v1.0 for insightful analysis of the human exome via next-generation sequencing. By using the research panel with xGen Lockdown Reagents and the optimised protocol, scientists can obtain reproducible exome data in a single day, minimising the need for added downstream analysis.


QIAGEN Clinical Insight bioinformatics platform expanded

06 November, 2015

The QIAGEN Clinical Insight (QCI) clinical decision support solution streamlines the annotation, interpretation and reporting of next-generation sequencing results (NGS) for clinical laboratories. The bioinformatics platform has been expanded from interpreting NGS data on somatic mutations in solid tumour cancers to add leukaemia and lymphoma testing, as well as testing for hereditary cancer indications.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd